Home Tags Biocon

Biocon

Biocon Will Supply Seven Generic Drugs to Southeast Asian Markets

Biocon Ltd and DKSH, a leading market expansion services provider with a focus on Asia, announced that Biocon’s subsidiary, Biocon Pharma Limited and DKSH...

Biocon Biologics Receive EU GMP Certification for API Facilities

Biocon Biologics India Ltd., a subsidiary of Biocon Ltd. has received the Certificate of GMP compliance from EMA represented by the competent authority of...

Biocon and Mylan Launch Biosimilar Neulasta in Canada

Biocon and Mylan NV have jointly launched Fulphila, a biosimilar to Neulasta (pegfilgrastim), in Canada for cancer patients. Fulphila, which was launched in Australia two...

Biocon’s Insulin Plant in Malaysia Receives EIR from FDA with VAI Classification

Biocon reported the FDA has closed the pre-inspection of the plant for its insulin glargine, tagging the facility with a voluntary action indicated (VAI),...

FDA Inspection Has Found a Handful of Issues with Biocon Plant

The FDA has found a handful of issues with Biocon's small molecules API manufacturing in Bengaluru, India. The company reported that the agency issued a...
20,111FansLike
2,238FollowersFollow
2,275SubscribersSubscribe

Hot Topics

Veklury is the First Approved Treatment Option for COVID-19 in the European Union

Gilead Sciences, Inc. announced that the European Commission has granted conditional marketing authorization for Veklury® (remdesivir) as a treatment for SARS-CoV-2 infection, the virus...

The Approval of Fostemsavir Gives a Sense of New Hope for People Living with HIV

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, announced that the US Food...

Asian Countries are Interested in Drugs for the Treatment of COVID-19 Russian Production

Asian countries have expressed an interest in Russian-procuced drugs and vaccines against COVID-19, a disease caused by the novel coronavirus, Russian Deputy Foreign Minister...